Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2121353119. doi: 10.1073/pnas.2121353119. Epub 2022 Mar 7.
SignificanceThe nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain containing 3 (NLRP3) is a pattern recognition receptor that forms an inflammasome. The cryo-electron microscopy structure of the dodecameric form of full-length NLRP3 bound to the clinically relevant NLRP3-specific inhibitor MCC950 has established the structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation and the mechanism of action of the NLRP3 specific inhibitor. The inactive NLRP3 oligomer represents the NLRP3 resting state, capable of binding to membranes and is likely disrupted for its activation. Visualization of the inhibitor binding mode will enable optimization of the activity of NLRP3 inflammasome inhibitor drugs.
意义
核苷酸结合寡聚结构域(NOD)样受体富含亮氨酸重复序列 3(NLRP3)是一种模式识别受体,能够形成炎症小体。全长 NLRP3 与临床相关的 NLRP3 特异性抑制剂 MCC950 结合的十二聚体形式的冷冻电子显微镜结构,为 NLRP3 炎症小体激活的寡聚体介导调节以及 NLRP3 特异性抑制剂的作用机制奠定了结构基础。无活性的 NLRP3 寡聚体代表了 NLRP3 的静止状态,能够与膜结合,并且可能由于其激活而被破坏。抑制剂结合模式的可视化将能够优化 NLRP3 炎症小体抑制剂药物的活性。